Bristol-Myers, Pfizer To Seek Europe OK For Anticlotting Drug
Bristol-Myers Squibb Co. (BMY) and Pfizer Inc. (PFE) said Friday they plan to seek regulatory approval of anticlotting therapy apixaban in Europe in the first half of next year.
Nasdaq,
Fri Dec 04 16:16:59 PST 2009
• Found on Yahoo! News
Bristol-Myers Squibb And Pfizer Announce Plans To Submit Regulatory Filing For Api...
Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer (NYSE: PFE) today announced that the companies are planning ...
Finanzen.net,
Fri Dec 04 15:35:48 PST 2009
• Found on Yahoo! News
Topix.net
360,000 news channels, from Autos to your ZIP code.
• Found on Topix News
Pfizer exec named chief of staff to NJ gov-elect
TRENTON
Asbury Park Press,
Fri Dec 04 05:35:34 PST 2009
• Found on Yahoo! News
ADDING MULTIMEDIA Bristol-Myers Squibb And Pfizer Announce Plans To Submit Regulat...
PRINCETON, N.J. & NEW YORK----Bristol-Myers Squibb Company and Pfizer today announced that the companies are planning to submit an application for regulatory approval of apixaban in Europe ...
Business Wire via Yahoo! Finance,
Fri Dec 04 16:35:00 PST 2009
• Found on Yahoo! News
Pfizer to present study findings from its expanded breast cancer portfolio
Pfizer Oncology announced today that it will be presenting study findings evaluating several compounds including those from its newly expanded breast cancer portfolio following the recent a...
News-Medical-Net,
Fri Dec 04 06:00:30 PST 2009
• Found on Yahoo! News
Pfizer files notice of 200 layoffs at Pearl River site
PEARL RIVER
The Journal News,
Thu Dec 03 23:51:16 PST 2009
• Found on Yahoo! News
Fear inspires Pfizer reform
It is great to hear Pfizer CEO Jeffrey B.
The Day,
Thu Dec 03 23:13:10 PST 2009
• Found on Yahoo! News
Pfizer announces a $9M cancer research collaboration in British Columbia
Pfizer is entering into a three-year, $9-million research collaboration with the BC Cancer Agency and the Vancouver Prostate Centre, a University of British Columbia (UBC) and Vancouver Gen...
News-Medical-Net,
Fri Dec 04 00:45:24 PST 2009
• Found on Yahoo! News
Mintz Levin Intellectual Property Practice Represents Protalix in $60 Million Lice...
BOSTON----Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. represented Protalix , a leading biopharmaceutical company, in its licensing agreement with Pfizer Inc. to develop and commerci...
Business Wire via Yahoo! Finance,
Fri Dec 04 08:13:00 PST 2009
• Found on Yahoo! News
Pfizer donates $9 million to B.C. cancer researchers
Pfizer Canada is giving $9 million to B.C. health organizations for research into new treatments for breast, ovarian and prostate cancer, the pharmaceutical company announced Thursday.
Vancouver Sun,
Fri Dec 04 00:03:02 PST 2009
• Found on Yahoo! News
Pfizer exec's health-funding job defended
Health Minister Leona Aglukkaq is not reconsidering the appointment of Bernard Prigent, a senior pharmaceutical executive at Pfizer Canada, to the governing council of the federal governmen...
CBC via Yahoo! Canada News,
Thu Dec 03 12:07:49 PST 2009
• Found on Yahoo! News
Pfizer Deal Signals Move Into Rare Diseases
The world
New York Times,
Wed Dec 02 02:11:31 PST 2009
• Found on Yahoo! News
Pfizer chief prescribes trust
BOSTON, Dec. 2 (UPI) -- Pfizer Inc. Chief Executive Officer Jeffrey Kindler said the U.S. drugmaker, fined $2.3 billion for illegal marketing, needed to "earn" the public's trust.
UPI,
Wed Dec 02 12:59:36 PST 2009
• Found on Yahoo! News
Pfizer CEO issues a warning to Corporate America: MedCity Morning Read, Dec. 3, 20...
Image via Wikipedia Highlights of the important and the interesting in the world of health care: Pfizer CEO warns of "real and legitimate" public anger at corporations: Pfizer CEO Jeffrey K...
MedCity News,
Thu Dec 03 05:36:11 PST 2009
• Found on Yahoo! News
Pfizer And Protalix Enter Into Agreement To Develop And Commercialize Gaucher's Di...
Pfizer and Protalix recently announced that they have entered into an agreement to develop and commercialize taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD) in d...
PharmaceuticalOnline,
Wed Dec 02 22:53:55 PST 2009
• Found on Yahoo! News
Pfizer, Protalix enter pact to develop & commercialize Gaucher's disease drug tali...
Pfizer and Protalix have entered into an agreement to develop and commercialize taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD) in development for the potential ...
PharmaBiz,
Wed Dec 02 21:51:25 PST 2009
• Found on Yahoo! News
The man from Pfizer: Should Big Pharma help steer health research?
The appointment of a Pfizer Canada vice-president to the governing council of the Canadian Institutes of Health Research raises issues
The Globe and Mail,
Thu Dec 03 07:24:00 PST 2009
• Found on Yahoo! News
Pfizer inks deal for new drugmaking technology
Pfizer Inc. will spend up to $115 million for rights to an Israeli biotech company's experimental drug and its promising technology for making that drug and others in carrot cells.
AP via Yahoo! News,
Tue Dec 01 13:34:11 PST 2009
• Found on Yahoo! News
Pfizer And Protalix Enter Into Agreement To Develop And Commercialize Gaucher's Di...
Pfizer (NYSE: PFE) and Protalix (NYSE-Amex: PLX) today announced that they have entered into an agreement to develop and commercialize taliglucerase alfa, a plant-cell expressed form of glu...
Medical News Today,
Wed Dec 02 07:11:36 PST 2009
• Found on Yahoo! News